Michel Monod
Overview
Explore the profile of Michel Monod including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
3661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poirier W, Faway E, Yamada T, Ozawa K, Marechal F, Monod M, et al.
Mycoses
. 2025 Feb;
68(2):e70037.
PMID: 39980131
Background: Trichophyton benhamiae is a common dermatophyte whose natural host is the guinea pig and which causes highly inflammatory skin lesions in humans. The subtilisin 6 (SUB6) of this fungus...
2.
Moreno-Sabater A, Cordier C, Normand A, Bidaud A, Cremer G, Bouchara J, et al.
Clin Microbiol Infect
. 2024 Aug;
30(12):1613-1615.
PMID: 39127108
No abstract available.
3.
Ishii M, Yamada T, Ishikawa K, Ichinose K, Monod M, Ohata S
Antimicrob Agents Chemother
. 2024 Apr;
68(5):e0160923.
PMID: 38567956
The increasing prevalence of dermatophyte resistance to terbinafine, a key drug in the treatment of dermatophytosis, represents a significant obstacle to treatment. is the most commonly isolated fungus in dermatophytosis....
4.
Uhrlass S, Mey S, Koch D, Mutze H, Kruger C, Monod M, et al.
Mycoses
. 2024 Mar;
67(4):e13718.
PMID: 38551112
Background: Dermatomycoses count to the most frequent dermatoses in Cambodia. Objectives: The aim of this survey was to investigate the occurrence of dermatophytes in this Southeast Asian country. Methods: From...
5.
Nenoff P, Stahl M, Schaller M, Burmester A, Monod M, Ebert A, et al.
Dermatologie (Heidelb)
. 2023 Oct;
74(11):864-873.
PMID: 37823916
For more than 30 years, an 82-year-old man has been suffering from tinea corporis generalisata in the sense of Trichophyton rubrum syndrome. The patient received long-term treatment with terbinafine. Fluconazole...
6.
Yamada T, Maeda M, Nagai H, Salamin K, Chang Y, Guenova E, et al.
Antimicrob Agents Chemother
. 2023 Oct;
67(11):e0093323.
PMID: 37823662
is an emerging dermatophyte that causes severe tinea corporis and tinea cruris. Numerous cases of terbinafine- and azole-recalcitrant -related dermatophytosis have been observed in India over the past decade, and...
7.
Blanchard G, Amarov B, Fratti M, Salamin K, Bontems O, Chang Y, et al.
J Eur Acad Dermatol Venereol
. 2023 Jun;
37(10):2080-2089.
PMID: 37319111
Background: Fungal infections are the most frequent dermatoses. The gold standard treatment for dermatophytosis is the squalene epoxidase (SQLE) inhibitor terbinafine. Pathogenic dermatophytes resistant to terbinafine are an emerging global...
8.
Monod M, Blanchard G, Guenova E
J Invest Dermatol
. 2023 Jun;
143(12):2332-2334.
PMID: 37302619
No abstract available.
9.
Blanchard M, Norrenberg S, Monod M, Morren M, Guenova E
Rev Med Suisse
. 2023 Mar;
19(820):618-623.
PMID: 36988169
Tinea capitis is a superficial dermatophytic infection of the scalp. This common dermatosis occurs predominantly in children. The clinical manifestation of the disease is heterogeneous, and vary widely depending on...
10.
Fratti M, Bontems O, Salamin K, Guenova E, Monod M
J Fungi (Basel)
. 2023 Feb;
9(2).
PMID: 36836366
Most inflammatory dermatophytoses in humans are caused by zoophilic and geophilic dermatophytes. Knowledge of the epidemiology of these fungi in animals facilitates the prevention of dermatophytosis of animal origin in...